Trial
NCT03443622
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors
Phase IWITHDRAWNSAFETYConfidence: HIGH
Sponsor
SupremeCure Pharma Inc.
Collaborators
—
Condition
Refractory Solid Tumor
Intervention
SC-43 Oral Solution
Why stopped
Another study has been started in other country.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-22